ROThe article discusses the challenges faced by patients in Romania who suffer from rare autoimmune diseases, using the case of Elena Mărginean, diagnosed with myasthenia gravis. It highlights the lack of access to innovative treatments compared to other European countries, noting that Romanian patients wait over 1,100 days for such therapies—longer than any other country in Europe. The article emphasizes the financial burden of new treatments, which can cost between €8,000 and €10,000 per course, making them inaccessible for most patients. It also describes the physical and emotional toll of living with a 'hidden' illness and the limited effectiveness of older medications.
Procjena pristranosti (Lijevo): The article frames the issue as a systemic failure of the Romanian healthcare system, emphasizing the disparity in treatment access compared to other EU nations. It uses emotive language to highlight patient suffering and criticizes the state’s inability to provide timely care. While it does not use
